user

BENEFIT-RISK ASSESSMENT TODAY

被引：1
|
作者：
HALL, RE
机构：
来源：
JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY | 1978年 / 55卷 / 01期
关键词：
D O I：
10.1007/BF02673417
中图分类号：
O69 [应用化学];
学科分类号：
081704 ;
摘要：
引用
下载
收藏
页码：193 / 197
页数：5
相关论文
共 50 条
  • [1] Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report
    Warner, Margaret R.
    Wolka, Anne M.
    Noel, Rebecca A.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (03) : 342 - 346
  • [2] Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report
    Margaret R. Warner
    Anne M. Wolka
    Rebecca A. Noel
    Therapeutic Innovation & Regulatory Science, 2016, 50 : 342 - 346
  • [3] Benefit-risk assessment of vaccines
    Kochhar, Sonali
    Izurieta, Hector S.
    Chandler, Rebecca E.
    Hacker, Adam
    Chen, Robert T.
    Levitan, Bennett
    VACCINE, 2024, 42 (04) : 969 - 971
  • [4] Estimand in benefit-risk assessment
    Ren, Xinru
    Chen, X. Gregory
    Seifu, Yodit
    Wang, William
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2023, 33 (04) : 452 - 465
  • [5] Benefit-risk assessment of acne therapies
    Seukeran, DC
    Eady, EA
    Cunliffe, WJ
    LANCET, 1997, 349 (9060): : 1251 - 1252
  • [6] Benefit-risk assessment of vaccination strategies
    Hanslik, Thomas
    Boelle, Pierre Yves
    M S-MEDECINE SCIENCES, 2007, 23 (04): : 391 - 398
  • [7] Methods of therapeutic benefit-risk assessment
    Moride, Yola
    Lynd, Larry
    Abenhaim, Lucien
    Moore, L.
    Kurz, Xavier
    Hartford, Craig
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S1 - S1
  • [8] A Bayesian Approach for Benefit-Risk Assessment
    Zhao, Yueqin
    Zalkikar, Jyoti
    Tiwari, Ram C.
    LaVange, Lisa M.
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2014, 6 (04): : 326 - 337
  • [9] Benefit-Risk Assessment of Nonprescription Diclofenac
    Brass, Eric P.
    Swanson, Jessica
    Weisman, Steven M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 464 - 465
  • [10] Structured benefit-risk evaluation for medicinal products: review of quantitative benefit-risk assessment findings in the literature
    Kurzinger, Marie-Laure
    Douarin, Ludivine
    Uzun, Ievgeniia
    El-Haddad, Chantal
    Hurst, William
    Juhaeri, Juhaeri
    Tcherny-Lessenot, Stephanie
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11
12345